No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Profound Medical Successfully Prices Public Offering to Boost Commercialization Efforts
Chairman of the Board & CEO of Profound Medical Picks Up 3.7% More Stock
Express News | Profound Medical Corp : Raymond James Cuts Target Price to $17 From $19
Raymond James Initiates Profound Medical(PROF.US) With Buy Rating, Announces Target Price $17
Profound Medical | 6-K: Report of foreign private issuer (related to financial reporting)
Profound Stock Slides 6% on $35M Public Offering Pricing
No Data